{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:54:33Z","timestamp":1783396473658,"version":"3.54.6"},"reference-count":35,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TCRM"],"DOI":"10.2147\/tcrm.s529550","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:05:13Z","timestamp":1768320313000},"page":"1-16","source":"Crossref","is-referenced-by-count":1,"title":["Real-World Clinical Effectiveness and Migraine-Related Healthcare Resource Utilization in Patients Initiating Fremanezumab in Germany and the United Kingdom"],"prefix":"10.2147","volume":"Volume 22","author":[{"given":"Axel","family":"Heinze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazia","family":"Afridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0253-325X","authenticated-orcid":true,"given":"Todor","family":"Totev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Krasenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Terasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Akcicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Hipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalbir","family":"Dhiraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Yim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binyam","family":"Yilma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Driessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204\u20131222. doi:10.1016\/S0140-6736(20)30925-9","DOI":"10.1016\/S0140-6736(20)30925-9"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s10194-018-0846-2","volume":"19","author":"Steiner","year":"2018","journal-title":"J Headache Pain"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e551","DOI":"10.1016\/S2468-2667(20)30190-0","volume":"5","author":"Deuschl","year":"2020","journal-title":"Lancet Public Health"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","volume":"19","author":"Feigin","year":"2020","journal-title":"Lancet Neurol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s10194-018-0946-z","volume":"19","author":"Martelletti","year":"2018","journal-title":"J Headache Pain"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"American Headache Society. The American Headache Society position statement on integrating new migraine treatments into clinical practice. Headache. 2019;59(1):1\u201318. doi:10.1111\/head.13456","DOI":"10.1111\/head.13456"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/head.13407","volume":"58","author":"Lipton","year":"2018","journal-title":"Headache"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s40001-022-00716-w","volume":"27","author":"Sevivas","year":"2022","journal-title":"Eur J Med Res"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1212\/CON.0000000000000199","volume":"21","author":"Silberstein","year":"2015","journal-title":"Continuum (Minneap Minn)"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S0140-6736(19)31946-4","volume":"394","author":"Ferrari","year":"2019","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s40261-025-01433-y","volume":"45","author":"Hajjaj","year":"2025","journal-title":"Clin Drug Investig"},{"key":"ref12","unstructured":"NICE. Technology appraisal guidance [TA764]: fremanezumab for preventing migraine; 2022. Available from: https:\/\/www.nice.org.uk\/guidance\/ta764\/evidence. Accessed June 22, 2023."},{"key":"ref13","unstructured":"AJOVY\u00ae (fremanezumab) [therapeutic indication]. Berlin, Germany: Federal Joint Committee; 2019."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s10194-022-01411-1","volume":"23","author":"Driessen","year":"2022","journal-title":"J Headache Pain"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.33140\/an.05.02.01","volume":"5","author":"Cheng","year":"2022","journal-title":"Adv Neurol Neurosci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/03331024241280496","volume":"44","author":"Ahmed","year":"2024","journal-title":"Cephalalgia"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s40120-024-00591-z","volume":"13","author":"Barbanti","year":"2024","journal-title":"Neurol Ther"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"P040","DOI":"10.1186\/s10194-024-01793-4","volume":"25","author":"Straube","year":"2024","journal-title":"J Headache Pain"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"P025","DOI":"10.1186\/s10194-024-01793-4","volume":"25","author":"Straube","year":"2024","journal-title":"J Headache Pain"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"EPV","DOI":"10.1111\/ene.16131","volume":"31","author":"Ashina","year":"2024","journal-title":"Eur J Neurol"},{"key":"ref21","unstructured":"National Institute for Health and Care Excellence. Fremanezumab for preventing migraine: technology appraisal guidance (TA764); 2022."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1212\/WNL.56.suppl_1.S20","volume":"56","author":"Stewart","year":"2001","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1177\/0333102410379890","volume":"31","author":"Yang","year":"2011","journal-title":"Cephalalgia"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1080\/10629360600635245","volume":"77","author":"Shieh","year":"2007","journal-title":"J Stat Comp Sim"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1177\/0333102411398400","volume":"31","author":"Lanteri-Minet","year":"2011","journal-title":"Cephalalgia"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s10194-018-0875-x","volume":"19","author":"Vandenbussche","year":"2018","journal-title":"J Headache Pain"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s10194-019-1015-y","volume":"20","author":"Hjalte","year":"2019","journal-title":"J Headache Pain"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/ene.15563","volume":"30","author":"Vernieri","year":"2023","journal-title":"Eur J Neurol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/head.14032","volume":"61","author":"Barbanti","year":"2021","journal-title":"Headache"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s40122-024-00583-9","volume":"13","author":"Buse","year":"2024","journal-title":"Pain Ther"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s10194-021-01358-9","volume":"22","author":"McAllister","year":"2021","journal-title":"J Headache Pain"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/0333102410381145","volume":"31","author":"Blumenfeld","year":"2011","journal-title":"Cephalalgia"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s10194-020-01130-5","volume":"21","author":"Sacco","year":"2020","journal-title":"J Headache Pain"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s10194-022-01431-x","volume":"23","author":"Sacco","year":"2022","journal-title":"J Headache Pain"}],"container-title":["Therapeutics and Clinical Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/110992","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/110992","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:05:15Z","timestamp":1768320315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/real-world-clinical-effectiveness-and-migraine-related-healthcare-reso-peer-reviewed-fulltext-article-TCRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":35,"URL":"https:\/\/doi.org\/10.2147\/tcrm.s529550","relation":{},"ISSN":["1178-203X"],"issn-type":[{"value":"1178-203X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}